Jintian Pharmaceutical Group Limited provided earnings guidance for the six months ended June 30, 2014. For the six months, the company expects to record a substantial increase in its consolidated net profit for the six months ended 30 June 2014 as compared to that for the corresponding period in 2013, which is mainly attributable to a substantial growth in both the retail and distribution businesses.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 HKD | +11.76% | 0.00% | -42.42% |
28/02 | Universal Health International Group's Fiscal H1 Loss Narrows | MT |
27/02 | Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-42.42% | 43.58L | |
+23.92% | 7.46TCr | |
-2.46% | 2.39TCr | |
+10.52% | 851.53Cr | |
+5.62% | 854.79Cr | |
-21.71% | 784.67Cr | |
+11.90% | 518.34Cr | |
+2.61% | 416.72Cr | |
-4.23% | 405.81Cr | |
+5.42% | 388.65Cr |
- Stock Market
- Equities
- 2211 Stock
- News Universal Health International Group Holding Limited
- Jintian Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2014